Datasheet

Bifidobacterium bifidum; 20215 (CAT#: LBST-051FG)

Bifidobacterium bifidum was isolated from adult intestine. It is an essential bacteria found in the human intestine.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

CAT Size Price Quantity  
LBST-051FG
Product Information
Product Overview Bifidobacterium bifidum was isolated from adult intestine. It is an essential bacteria found in the human intestine.
Target Bifidobacterium
Genus Bifidobacterium
Application Study and research
Type Strain No
Culture Medium BBL
Culture Conditions 37°C; Anaerobic
Source Adult intestine
Risk Group 1
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction Bifidobacterium are Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They are originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS; Generally Recognised As Safe status.
Alternative Names Bifidobacterium bifidum; 20215
FAQs Customer Reviews Related Products
  1. What are the key features and benefits of using Bifidobacterium bifidum in scientific research?

    Bifidobacterium bifidum is valued for its potential health benefits, including probiotic effects on gut microbiota balance and immune system modulation. Researchers utilize it to study its impact on digestive health and microbial interactions.

  2. How should I prepare and standardize Bifidobacterium bifidum cultures for experimental use?

    Start by thawing frozen stocks gently and inoculating them into fresh growth medium suitable for Bifidobacterium species. Incubate under anaerobic conditions at a controlled temperature (typically 37°C) to maintain viability and purity throughout experiments.

  3. What are the recommended methods for assessing the viability and activity of Bifidobacterium bifidum in experimental models?

    Use viability assays such as CFU counting on selective media or metabolic activity tests like SCFA production assays. Additionally, molecular techniques such as qPCR can quantify Bifidobacterium bifidum DNA/RNA levels in complex biological samples.

  4. Can Bifidobacterium bifidum be used in combination with other probiotics or prebiotics?

    Yes, researchers often combine Bifidobacterium bifidum with other probiotic strains or prebiotic substrates to enhance its beneficial effects on gut health. Investigate synergistic interactions through co-culture studies and metabolic profiling to optimize therapeutic outcomes.

  5. What are the considerations for conducting In vivo studies using Bifidobacterium bifidum?

    Prioritize animal models with relevant physiological similarities to humans, ensuring proper ethical approvals and compliance with animal welfare guidelines. Monitor host responses and gut microbiota dynamics using non-invasive techniques to validate therapeutic efficacy.

  • Enhanced Research Potential
    Creative Biolabs' Bifidobacterium bifidum; 20215 facilitates groundbreaking research in gut microbiota modulation, surpassing competitors with its robust strain specificity and reproducibility.
  • Reliable Performance in Complex Models
    The efficacy of Bifidobacterium bifidum; 20215 in preclinical studies outshines other probiotics, demonstrating significant immune system interactions and metabolic benefits crucial for therapeutic innovations.
  • Efficient Host-Microbe Interactions
    With a focus on host-microbe interactions, Creative Biolabs' Bifidobacterium bifidum; 20215 stands out for its ability to modulate inflammatory responses and improve intestinal barrier function, crucial for therapeutic advances.
  • Leader in Microbial Dynamics
    Researchers favor Bifidobacterium bifidum; 20215 for its role in elucidating microbial community dynamics. Its precision in modulating gut health markers sets it apart, pivotal for next-gen drug developments.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket
Advertisement